The Renal Association has produced guidance on best practice in the management of patients with kidney disease since 1995. The current editions of the Guidelines can be found in the table below, along with commentaries on other relevant guidelines.
|Guideline||Authors||Publication Date||Review Date|
|Acute Kidney Injury (AKI)||Suren Kanagasundaram, Caroline Ashley, Sheetal Bhojani, Alma Caldwell, Timothy Ellam, Amrit Kaur, David Milford, Chris Mulgrew, Marlies Ostermann||August 2019||2024|
|Anaemia of Chronic Kidney Disease||Ashraf Mikhail, Christopher Brown, Jennifer Ann Williams, Vinod Mathrani, Rajesh Shrivastava, Jonathan Evans, Hayleigh Isaac & Sunil Bhandari||June|
|Commentary on the KDIGO Guideline on the Diagnosis, Evaluation, Prevention and Treatment of CKD-MBD||James Burton, David Goldsmith, Nicki Ruddock, Rukshana Shroff & Mandy Wan||June |
|Commentary on the NICE Guideline on Tolvaptan for treating autosomal dominant polycystic kidney disease||Albet CM Ong, Caroline Ashley, Tess Harris, Richard Sandford, John A Sayer, Roslyn J Simms & Grahame Wood||June|
|Haemodialysis||Damien Ashby, Natalie Borman, James Burton, Richard Corbett, Andrew Davenport, Ken Farrington, Katey Flowers, James Fotheringham, Andrea Fox, Gail Franklin, Claire Gardiner, Martin Gerrish, Sharlene Greenwood, Daljit Hothi, Abdul Khares, Pelagia Koufaki, Jeremy Levy, Elizabeth Lindley, Jamie Macdonald, Bruno Mafrici, Andrew Mooney, James Tattersall, Kay Tyerman, Enric Villar & Marin Wilkie||July |
|Living donor kidney transplantation||Peter Andrews & Lisa Burnapp|
Endorsed by the British Transplantation Society
|Management of Blood Borne Viruses within the Haemodialysis Unit||Elizabeth Garthwaite, Veena Reddy, Sam Douthwaite, Simon Lines, Kay Tyerman & James Eccles||June 2019||2024|
| Monitoring children and young people with, or at risk of developing Autosomal Dominant Polycystic Kidney Disease (ADPKD)||Jan Dudley, Paul Winyard, Matko Marlais, Oliver Cuthell, Tess Harris, Jiehan Chong, John Sayer, |
Daniel P Gale, Lucy Moore, Kay Turner, Sarah Burrows & Richard Sandford
|Perioperative management of people with inherited salt-wasting alkaloses (Gitelman’s syndrome and Bartter’s syndrome) undergoing non-urgent surgical procedure|| Hugh Gallagher, Jasmeet Soar & Charles Tomson|
Endorsed by the Royal College of Anaesthetists
|Peritoneal Dialysis in Adults and Children||Graham Woodrow, Stanley Fan, Christopher Reid, Jeannette Denning & Andrew Neil Pyrah||June|
|Planning, initiation & withdrawal of Renal Replacement Therapy||Graham Warwick, Andrew Mooney, Lynne Russon & Rebecca Hardy||January|
|Post-Operative Care in the Kidney Transplant Recipient||Richard Baker, Patrick Mark, Rajan Patel, Kate Stevens & Nicholas Palmer|
Endorsed by the British Transplantation Society
|Treatment of Acute Hyperkalaemia in Adults|
Hyperkalaemia Cardiac Arrest Algorithm
|Annette Alfonzo, Jasmeet Soar, Robert MacTier, Jonathan Fox, Ilona Shillday, Jerry Nolan, Roop Kishen, Alistair Douglas, Bill Bartlett, Martin Wiese, Brenda Wilson, Jacqueline Beatson, Lyn Allen, Mumtaz Goolam & Morag Whittle|
Endorsed by the Resuscitation Council, the Intensive Care Society, the Faculty of Intensive Care Medicine, the Society for Acute Medicine; and the Royal College of Emergency Medicine
|Undernutrition in Chronic Kidney Disease||Mark Wright, Elizabeth Southcott, Helen MacLaughlin, Stuart Wineberg||June 2019||2024|
|Vascular Access for Haemodialysis||Mick Kumwenda, Sandip Mitra |
& Claire Reid
|Water Treatment Facilities, Dialysis Water and Dialysis Fluid Quality for Haemodialysis and Related Therapies|| Nicholas Hoenich, Robert Mactier, Ian Morgan, Gerard Boyle, David Croft, Paul Rylance, Clive Thompson|
Endorsed by the Association of Renal Technologists
Further guidelines and commentaries are currently being written. Please see the Recent Activity page for more information.
The RA Clinical Practice Guidelines are not funded by any external organisation, commercial company or charity. Several of these guidelines have also been published in BMC Nephrology.
The guidelines have been accredited by the National Institute for Health and Care Excellence (NICE). The accreditation is valid until January 2022. This ensures that the Guidelines themselves will automatically be NICE accredited, providing they follow the processes laid out in the Clinical Practice Guideline Development Manual.
Accreditation helps health and social care professionals identify the most robustly produced guidance available, enabling them to deliver high quality care. More information on accreditation can be viewed at http://www.nice.org.uk/accreditation
The Renal Association’s Clinical Practice Guideline (CPG) committee have produced a Strategy Document to plan their work through until 2020.